Literature DB >> 20809404

[New TNM classification of malignant lung tumours].

J Wohlschläger1, C Wittekind, D Theegarten.   

Abstract

The staging system for lung tumours is now recommended for the classification of both non-small-cell and small-cell lung cancer as well as for carcinoid tumours of the lung. The T classifications have been redefined: T1 has been subclassified as T1a (≤ 2 cm in size) and T1b (> 2-3 cm in size). T2 has been subclassified as T2a (> 3-5 cm in size) and T2b (> 5-7 cm in size). T2 (> 7 cm in size) has been reclassified as T3. Multiple tumour nodules in the same lobe have been reclassified from T4 to T3. Multiple tumour nodules in the same lung but a different lobe have been reclassified from M1 to T4. No changes have been made in the N classification. The M classification has been redefined: M1 has been subdivided into M1a and M1b. Malignant pleural and pericardial effusions have been reclassified from T4 to M1a. Separate tumour nodules in the contralateral lung have been reclassified from T4 to M1a. M1b designates distant metastasis.

Entities:  

Mesh:

Year:  2010        PMID: 20809404     DOI: 10.1007/s00292-010-1303-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  18 in total

1.  Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.

Authors:  Kimihiro Shimizu; Junji Yoshida; Kanji Nagai; Mitsuyo Nishimura; Genichiro Ishii; Yasuo Morishita; Yutaka Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2005-07       Impact factor: 5.209

2.  Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.

Authors:  D Manac'h; M Riquet; J Medioni; F Le Pimpec-Barthes; A Dujon; C Danel
Journal:  Ann Thorac Surg       Date:  2001-04       Impact factor: 4.330

3.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

Review 4.  Should aggressive surgery ever be part of the management of small cell lung cancer?

Authors:  Thomas K Waddell; Frances A Shepherd
Journal:  Thorac Surg Clin       Date:  2004-05       Impact factor: 1.750

5.  [New TNM classification of malignant lung tumors 2009 from a pathology perspective].

Authors:  A Fisseler-Eckhoff
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

Review 6.  Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee.

Authors:  William D Travis
Journal:  Histopathology       Date:  2009-01       Impact factor: 5.087

7.  The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.

Authors:  Frances A Shepherd; John Crowley; Paul Van Houtte; Pieter E Postmus; Desmond Carney; Kari Chansky; Zeba Shaikh; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2007-12       Impact factor: 15.609

8.  Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment.

Authors:  Kimihiro Shimizu; Junji Yoshida; Kanji Nagai; Mitsuyo Nishimura; Tomoyuki Yokose; Genichiro Ishii; Yutaka Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2004-06       Impact factor: 5.209

Review 9.  The revised TNM staging system for lung cancer.

Authors:  Ramon Rami-Porta; John J Crowley; Peter Goldstraw
Journal:  Ann Thorac Cardiovasc Surg       Date:  2009-02       Impact factor: 1.520

10.  The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.

Authors:  Ramón Rami-Porta; David Ball; John Crowley; Dorothy J Giroux; James Jett; William D Travis; Masahiro Tsuboi; Eric Vallières; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2007-07       Impact factor: 15.609

View more
  6 in total

Review 1.  [Pathology of lung cancer].

Authors:  D Theegarten; T Hager
Journal:  Radiologe       Date:  2016-09       Impact factor: 0.635

2.  Painful neuropathy in a diabetic patient resulting from lung cancer and not diabetes: A case report.

Authors:  He-Bin Yao; Ya-Ning Chen; Jian Shang; Qiao-Jun Han
Journal:  Oncol Lett       Date:  2015-10-15       Impact factor: 2.967

3.  A novel staging model to classify oesophageal squamous cell carcinoma patients in China.

Authors:  H Tan; H Zhang; J Xie; B Chen; C Wen; X Guo; Q Zhao; Z Wu; J Shen; J Wu; X Xu; E Li; L Xu; X Wang
Journal:  Br J Cancer       Date:  2014-02-25       Impact factor: 7.640

4.  Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma.

Authors:  Jin-Cheng Guo; Yang Wu; Yang Chen; Feng Pan; Zhi-Yong Wu; Jia-Sheng Zhang; Jian-Yi Wu; Xiu-E Xu; Jian-Mei Zhao; En-Min Li; Yi Zhao; Li-Yan Xu
Journal:  Cancer Commun (Lond)       Date:  2018-04-09

5.  PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18.

Authors:  Jie Tang; Qinge Meng; Ruirui Shi; Youqi Xu
Journal:  Mol Med Rep       Date:  2020-08-03       Impact factor: 2.952

6.  Recommended changes for the 8th edition of the TNM classification for lung cancer-the findings of a single-institution evaluation.

Authors:  Jia Wang; Nan Wu; Chao Lv; Shi Yan; Yue Yang
Journal:  Ann Transl Med       Date:  2020-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.